{"id":44632,"date":"2022-06-02T19:01:25","date_gmt":"2022-06-02T17:01:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/"},"modified":"2022-06-02T19:01:25","modified_gmt":"2022-06-02T17:01:25","slug":"global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/","title":{"rendered":"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) &#8211; Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5595704\/global-bipolar-disorder-drugs-and-treatment?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cdxhzd&amp;utm_campaign=1708828+-+Global+Bipolar+Disorder+Drugs+and+Treatment+Market+Report+(2022+to+2032)+-+Featuring+Astellas+Pharma%2C+Bristol+Myers+Squibb+and+Gedeon+Richter+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Bipolar Disorder Drugs and Treatment Market 2022-2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220602005814\/en\/1475038\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220602005814\/en\/1475038\/21\/logo.jpg\"><\/a><\/p>\n<p>\nA recent market study published on the market offers global industry analysis for 2014-2021 &amp; opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics.\n<\/p>\n<p>\nAfter conducting thorough research on the historical and current growth parameters of the Bipolar Disorder Drugs and Treatment Market, the growth prospects of the market are obtained with maximum precision.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbvie Inc.\n<\/li>\n<li>\nGlaxo Smithkline (Gsk)\n<\/li>\n<li>\nEli, Lily and Company\n<\/li>\n<li>\nJanssen Pharmaceuticals\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nAstellas Pharma Inc\n<\/li>\n<li>\nBristol Myers Squibb\n<\/li>\n<li>\nGedeon Richter plc.\n<\/li>\n<li>\nH. Lundbeck A\/S\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nOtsuka Holdings Co. Ltd\n<\/li>\n<li>\nValidus Pharmaceuticals LLC.\n<\/li>\n<\/ul>\n<p>\n<strong>Market Segmentation<\/strong>\n<\/p>\n<p>\nThe Bipolar Disorder Drugs and Treatment Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.\n<\/p>\n<p>\n<strong>By Drug Class<\/strong>\n<\/p>\n<ul>\n<li>\nMood Stabilizers\n<\/li>\n<li>\nAnticonvulsants\n<\/li>\n<li>\nAntipsychotic Drugs\n<\/li>\n<li>\nAntidepressant Drugs\n<\/li>\n<li>\nAnti-anxiety Drugs\n<\/li>\n<\/ul>\n<p>\n<strong>By Region<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nAsia Pacific\n<\/li>\n<li>\nMiddle East and Africa (MEA)\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>2. Market Overview<\/strong>\n<\/p>\n<p>\n<strong>3. Market Background<\/strong>\n<\/p>\n<p>\n<strong>4. Global Bipolar Disorder Drugs and Treatment Market Analysis 2017-2021 and Forecast, 2022-2032<\/strong>\n<\/p>\n<p>\n<strong>5. Global Bipolar Disorder Drugs and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Drug Class<\/strong>\n<\/p>\n<p>\n<strong>6. Global Bipolar Disorder Drugs and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region<\/strong>\n<\/p>\n<p>\n<strong>7. North America Bipolar Disorder Drugs and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country<\/strong>\n<\/p>\n<p>\n<strong>8. Latin America Bipolar Disorder Drugs and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country<\/strong>\n<\/p>\n<p>\n<strong>9. Europe Bipolar Disorder Drugs and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country<\/strong>\n<\/p>\n<p>\n<strong>10. Asia Pacific Bipolar Disorder Drugs and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country<\/strong>\n<\/p>\n<p>\n<strong>11. Middle East and Africa Bipolar Disorder Drugs and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country<\/strong>\n<\/p>\n<p>\n<strong>12. Key Countries Bipolar Disorder Drugs and Treatment Market Analysis<\/strong>\n<\/p>\n<p>\n<strong>13. Market Structure Analysis<\/strong>\n<\/p>\n<p>\n<strong>14. Competition Analysis<\/strong>\n<\/p>\n<p>\n<strong>15. Assumptions &amp; Acronyms Used<\/strong>\n<\/p>\n<p>\n<strong>16. Research Methodology<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5595704\/global-bipolar-disorder-drugs-and-treatment?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cdxhzd&amp;utm_campaign=1708828+-+Global+Bipolar+Disorder+Drugs+and+Treatment+Market+Report+(2022+to+2032)+-+Featuring+Astellas+Pharma%2C+Bristol+Myers+Squibb+and+Gedeon+Richter+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/8x1dlf<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x70;r&#x65;&#115;&#x73;&#64;r&#x65;&#115;&#x65;&#97;r&#x63;h&#x61;&#110;&#x64;&#109;a&#x72;k&#x65;&#116;&#x73;&#x2e;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;e&#x73;&#x73;&#64;r&#x65;&#x73;&#101;a&#x72;&#x63;&#104;a&#x6e;&#x64;&#109;a&#x72;&#107;&#101;t&#x73;&#46;c&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\nFor E.S.T. Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Bipolar Disorder Drugs and Treatment Market 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. A recent market study published on the market offers global industry analysis for 2014-2021 &amp; opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44632","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) - Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) - Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Bipolar Disorder Drugs and Treatment Market 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. A recent market study published on the market offers global industry analysis for 2014-2021 &amp; opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-02T17:01:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220602005814\/en\/1475038\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) &#8211; Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-02T17:01:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/\"},\"wordCount\":398,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220602005814\\\/en\\\/1475038\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) - Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220602005814\\\/en\\\/1475038\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-02T17:01:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220602005814\\\/en\\\/1475038\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220602005814\\\/en\\\/1475038\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) &#8211; Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) - Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) - Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Bipolar Disorder Drugs and Treatment Market 2022-2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. A recent market study published on the market offers global industry analysis for 2014-2021 &amp; opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-02T17:01:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220602005814\/en\/1475038\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) &#8211; Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-06-02T17:01:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/"},"wordCount":398,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220602005814\/en\/1475038\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/","name":"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) - Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220602005814\/en\/1475038\/21\/logo.jpg","datePublished":"2022-06-02T17:01:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220602005814\/en\/1475038\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220602005814\/en\/1475038\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-bipolar-disorder-drugs-and-treatment-market-report-2022-to-2032-featuring-astellas-pharma-bristol-myers-squibb-and-gedeon-richter-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Bipolar Disorder Drugs and Treatment Market Report (2022 to 2032) &#8211; Featuring Astellas Pharma, Bristol Myers Squibb and Gedeon Richter Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44632"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44632\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}